Zynex Appoints Steven Dyson as New CEO, Effective August 18, 2025

Published: 2025-06-30 12:20:24 ET ZYXI

Published on 06/30/2025 at 12:20

Zynex, Inc. announced the appointment of Steven Dyson as Chief Executive Officer, effective August 18, 2025. Thomas Sandgaard, who founded Zynex in 1996, will step back from day-to-day operations but remain actively involved as Chairman and Chair of the Board?s Technology Committee. The leadership transition comes as the company?s stock has experienced significant volatility, with shares down over 70% in the past year despite maintaining a strong current ratio of 3.46, indicating solid short-term liquidity.

Dyson brings over 25 years of experience in the medical technology sector, primarily through his leadership at Apax, a global private equity firm. His experience includes board and transaction roles with companies such as KCI, Rodenstock, Healthium Medtech, Unilabs, and Neuraxpharm. The new CEO will operate from Zynex headquarters in Colorado while maintaining a residence in London.

Dyson holds a B.A. from Oxford University and a Ph.D. from Cambridge University. The appointment represents a significant leadership change for the Colorado-based medical technology company as it works to enhance its growth strategy in the competitive healthcare device market.